[Metformin associates lactic acidosis]

Presse Med. 2012 Oct;41(10):907-16. doi: 10.1016/j.lpm.2012.01.030. Epub 2012 Feb 28.
[Article in French]

Abstract

Metformin Associates lactic acidosis (MALA) is a metabolic acidosis with higher anion gap, high levels of blood lactates and treatment by metformin. MALA is a very rare entity but is associated with high mortality (30 to 50%). The extrarenal blood purification may be necessary in emergency. Relatively good clinical tolerance contrasts with a very elevated serum lactate. There is always a trigger and hypovolemia is prevalent. MALA often occurs when its prescription is not indicated (renal failure, cardiac failure, hypovolemia, or patient aged over 80 years). Metformin must be stopped in situations of acute hypovolemia or frail patients as diuretics or blockers of the rennin-angiotensin-aldosterone system.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Acidosis, Lactic / chemically induced*
  • Acidosis, Lactic / diagnosis
  • Acidosis, Lactic / epidemiology
  • Acidosis, Lactic / therapy
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Male
  • Metformin / adverse effects*
  • Middle Aged
  • Models, Biological
  • Renal Dialysis

Substances

  • Hypoglycemic Agents
  • Metformin